Treatment of chronic nonhealing neurotrophic corneal epithelial defects with thymosin beta 4.
Dunn
Steven P
SP
Departments of Ophthalmology, Children's Hospital of Michigan, Detroit Medical Center, Wayne State University, Detroit, USA. stevenpdunn@ameritech.net
Heidemann
David G
DG
Chow
Christopher Y C
CY
Crockford
David
D
Turjman
Nabila
N
Angel
Janet
J
Allan
Christian B
CB
Sosne
Gabriel
G
D000369:Aged, 80 and over; D002908:Chronic Disease; D057176:Compassionate Use Trials; D003316:Corneal Diseases / Q000188:drug therapy* / Q000209:etiology; D048909:Diabetes Complications; D019573:Epithelium, Corneal / Q000187:drug effects* / Q000473:pathology; D005260:Female; D006563:Herpes Zoster Ophthalmicus / Q000209:etiology; D006801:Humans; D008297:Male; D008875:Middle Aged; D009883:Ophthalmic Solutions / Q000008:administration & dosage*; D013947:Thymosin / Q000008:administration & dosage*; D000099201:Thymosin beta(4)
D009883:Ophthalmic Solutions; D013947:Thymosin; D000099201:Thymosin beta(4)